Martin Shkreli Resigns From Turing Pharmaceuticals Following Arrest
One day after he was arrested on suspicions of security fraud, Martin Shkreli has resigned from his position as CEO of Turing Pharmaceuticals.
At Turing, Shkreli made headlines after he had notoriously jacked up prices of the life-saving drug Daraprim and jacking its price up from $13.50 to $750 per tablet. Ron Tilles, the chairman of Turing’s board of directors, will step in as CEO on an interim basis, according to NBC.
46m
7m
3m
59m
22m
8m
1m
4m
1m
1m
1m
1m
1m
41s
2m
2m
9m
16m
8m
30s
9m
21m
20m
56m
41m
1h 30m
2m
1h 42m
1h 34m
58m
20m
1m
47m
2m
2m
1h 25m
1h 25m
2m
1h 36m
22m
1h 25m
8m
2m
1h 36m
1m
1h 7m
57m
20m
51m
1m
42m
1h 17m
41m
59s
1m
1h 38m
22m
7m
20m
30s